A Trim21-GSDMD Axis Links Psychosocial Stress to IL-1β-Driven Neuroinflammation and Blood-Brain Barrier Dysfunction in a Rat Model of Repeated Social Defeat

View at publisher
Authors: Soni Tiwari, Zaidan Mohammed, Santi Ranjan Atta, Aryan Tiwari, Ekta Yadav, Shweta Kaushik, Amla Chopra, Itender Singh, Simantini Ghosh
Cited by: 2
References: 64

Abstract

The molecular trigger that transduces psychosocial stress into the release of the key pro-inflammatory cytokine interleukin-1β (IL-1β) has been a missing link in stress-related neuropathology. We identify the E3 ubiquitin ligase tripartite motif-containing protein 21 (TRIM21) as this critical upstream regulator. In a rat model of repeated social defeat stress, TRIM21 was upregulated in the hippocampus, brain microvasculature, and peripheral blood mononuclear cells (PBMCs). This upregulation correlated with anxiety-like behavior and cognitive deficits and was more pronounced in females. Mechanistically, TRIM21 directly interacts with and promotes the cleavage of gasdermin D (GSDMD), enabling the formation of membrane pores for the export of mature IL-1β. This TRIM21-GSDMD-IL-1β axis was functional in PBMCs, linking peripheral immune activation to behavioral pathology. In vivo knockdown of TRIM21 systemically attenuated this pathway, reducing IL-1β release and downstream NF-κB activation. This intervention rescued blood-brain barrier integrity, restored hippocampal synaptic density, and attenuated behavioral deficits. Pharmacological inhibition of GSDMD with disulfiram recapitulated the neuroprotective effects of TRIM21 knockdown, validating this axis as a druggable pathway for stress-induced pathology. Using an in vitro neurovascular model, we defined endothelial TRIM21 as a central mediator of this stress-induced inflammatory cascade. These findings establish TRIM21 as a pivotal stress-responsive node, bridging peripheral immune signaling to GSDMD-dependent neuroinflammation and blood-brain barrier disruption, thereby revealing a new mechanistic framework and potential therapeutic target for neuropsychiatric disorders.

Fields of Study & Subjects

Neuroinflammation and Neurodegeneration Mechanisms Tryptophan and brain disorders Gut microbiota and health

Publication details

Journal / source
ACS Chemical Neuroscience
Publisher
American Chemical Society (ACS)
Volume
17
Issue
7
Pages
1345–1361
Publication date
23 March 2026
Language
EN